Staphylococcus aureus peritonitis complicates peritoneal dialysis: Review of 245 consecutive cases

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 2, 2007, Pages 245-251

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Kwan, Bonnie Ching Ha ^a   Law, Man Ching ^a   Chung, Kwok Yi ^a   Yu, Samuel ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; STAPHYLOCOCCUS INFECTION;

FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; STAPHYLOCOCCAL INFECTIONS;

EID: 34548863682     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03180906     Document Type: Article

References (42)

1. Piraino B: Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 9: 1956-1964, 1998
2. Oreopoulos DG, Tzamaloukas AH: Peritoneal dialysis in the next millennium. Adv Ren Replace Ther 7: 338-346, 2000
3. Szeto CC, Wong TY, Leung CB, Wang AY, Law MC, Lui SF, Li PK: Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58: 400-407, 2000
4. Szeto CC, Chow KM, Wong TY, Leung CB, Wang AY, Lui SF, Li PK: Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal. J Am Soc Nephrol 13: 1040-1045, 2002
5. Szeto CC, Leung CB, Chow KM, Kwan BC, Law MC, Wang AY, Lui SF, Li PK: Change in bacterial aetiology of peritoneal-dialysis-related peritonitis over ten years: Experience from a center in South-East Asia. Clin Microbiol Infect 10: 837-839, 2005
6. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 18: 977-982, 2003
7. Bloembergen WE, Port FK: Epidemiological perspective on infections in chronic dialysis patients. Adv Ren Replace Ther 3: 201-207, 1996
8. Prowant B, Nolph K, Ryan L, Twardowski Z, Khanna R: Peritonitis in continuous ambulatory peritoneal dialysis: Analysis of an 8-year experience. Nephron 43: 105-109, 1986
9. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F: Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 32: 623-628, 1998
10. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, Harding G: Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 36: 1009-1013, 2000
11. de Lourdes Ribeiro de Souza da Cunha M, Montelli AC, Fioravante AM, Neves Batalha JE, Teixeira Caramori JC, Barretti P: Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol 64: 378-382, 2005
12. Peacock SJ, Howe PA, Day NP, Crook DW, Winearls CG, Berendt AR: Outcome following staphylococcal peritonitis. Perit Dial Int 20: 215-219, 2000
13. Piraino B, Perlmutter JA, Holley JL, Bernardini J: Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 13[Suppl 2]: S332-S334, 1993
14. Sesso R, Draibe S, Castelo A, Sato I, Leme I, Barbosa D, Ramos O: Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 31: 264-268, 1989
15. Oxton LL, Zimmerman SW, Roecker EB, Wakeen M: Risk factors for peritoneal dialysis-related infections. Perit Dial Int 14: 137-144, 1994
16. Pignatari A, Pfaller M, Hollis R, Sesso R, Leme I, Herwaldt L: Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol 28: 1898-1902, 1990
17. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC: Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 61-64, 1989
18. Swartz R, Messana J, Starmann B, Weber M, Reynolds J: Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 2: 1085-1091, 1991
19. Wanten GJ, van Cost P, Schneeberger PM, Koolen MI: Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: A prospective study. Perit Dial Int 16: 352-356, 1996
20. Gupta B, Bernardini J, Piraino B: Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 28: 415-419, 1996
21. Kim D, Tapson J, Wu G, Khanna R, Vas SI, Oreopoulos DG: Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 30: 494-497, 1984
22. Bunke CM, Brier ME, Golper TA: Outcomes of single organism peritonitis in peritoneal dialysis: Gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 52: 524-529, 1997
23. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L; ISPD Ad Hoc Advisory Committee: Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25: 107-131, 2005
24. Vas SI: Peritonitis during CAPD. A mixed bag. Perit Dial Bull 1: 47-49, 1981
25. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Huang CC, Kawaguchi Y, Piraino B, Riella M, Schaefer F, Vas S: Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 16: 557-573, 1996
26. Flanigan MJ, Hochstetler LA, Langholdt D, Lim VS: Continuous ambulatory peritoneal dialysis catheter infections: Diagnosis and management. Perit Dial Int 14: 248-254, 1994
27. National Committee for Clinical Laboratory Standards (NCCLS): Performance Standards for Antimicrobial Susceptibility Testing, 9th Informational Supplement [NCCLS document M100-S91, Villanova, NCCLS, 1999
28. Szeto CC, Chow VC, Chow KM, Lai RW, Chung KY, Leung CB, Kwan BC, Li PK: Enterobacteriaceae peritonitis complicating peritoneal dialysis: A review of 210 consecutive cases. Kidney Int 69: 1245-1252, 2006
29. Piraino B, Bernardini J, Sorkin M: The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 8: 436-440, 1986
30. Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia. FJ: Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 39: 1278-1286, 2002
31. Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO: Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 42: 350-354, 2003
32. Schaefer F, Klaus G, Muller-Wiefel DE, Mehls O: Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). J Am Soc Nephrol 10: 136-145, 1999
33. Szeto CC, Chow KM, Leung CB, Wong TY, Wu AK, Wang AY, Lui SF, Li PK: Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: A review of 104 cases. Kidney Int 59: 2309-2315, 2001
34. Visser CE, Brouwer-Steenbergen JJ, Schadee-Eestermans IL, Meijer S, Krediet RT, Beelen RH: Ingestion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli by human peritoneal mesothelial cells. Infect Immun 64: 3425-3428, 1996
35. Haslinger-Loffler B, Wagner B, Bruck M, Strangfeld K, Grundmeier M, Fischer U, Volker W, Peters G, Schulze-Osthoff K, Sinha B: Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells. Kidney Int 70: 1089-1098, 2006
36. Ritzau J, Hoffman RM, Tzamaloukas AH: Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis. Perit Dial Int 21: 471-479, 2001
37. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O'Brien M, Oxton L, Roecker EB, Engeseth S: Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 18: 225-231, 1991
38. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R: A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 27: 695-700, 1996
39. Hanevold CD, Fisher MC, Waltz R, Bartosh S, Baluarte HJ: Effect of rifampin on Staphylococcus aureus colonization in children on chronic peritoneal dialysis. Pediatr Nephrol 9: 609-611, 1995
40. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG: Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 18: 261-270, 1998
41. Safdar N, Narans L, Gordon B, Maki DG: Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: A prospective study comparing 32 methods. J Clin Microbiol 41: 3163-3166, 2003
42. Watanakunakorn C: Mode of action and in-vitro activity of vancomycin. J Antimicrob Chemother 14[Suppl D]:7-18, 1984